Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg

NCT00647972 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
32
Enrollment
INDUSTRY
Sponsor class

Stopped during Period 1 due to numerous orthostatic AEs that occurred. Subsequently, RLD was reduced to 5 mg due to safety concerns.

Conditions

Interventions

Sponsor

Mylan Pharmaceuticals Inc